Skip to Main Content

Paper Details

Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib.
Lung Cancer
1
2023
Author NameAffiliation
Daniel W KellyMemorial Sloan Kettering Cancer Center
Daniel R GomezMemorial Sloan Kettering Cancer Center
Nikolaus SchultzMemorial Sloan Kettering Cancer Center
Nikolaus SchultzMemorial Sloan Kettering Cancer Center
Alexander DrilonMemorial Sloan Kettering Cancer Center
  • 1 - 5

Datasets

Release 1.2